Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > April 14, 2020
Daily News
April 14, 2020
- FPMAJ Ups Ante for Drug Supply Coordination amid COVID-19 Crisis
April 14, 2020
- Sanofi Files Sutimlimab for Cold Agglutinin Disease in Japan
April 14, 2020
- Opdivo Adds New Indication for Esophageal Cancer in South Korea
April 14, 2020
- Tokushukai Preparing Model Formulary for 72 Group Hospitals; PPIs, Flu Drugs Eyed
April 14, 2020
- Daiichi Sankyo, Nagoya Institute of Technology, Mitsubishi UFJ Capital Pair Up on Research for Vision Restoration Gene Therapy
April 14, 2020
- Daiichi Sankyo Staffer in Toyama Infected with Coronavirus
April 14, 2020
- Healios to Enroll COVID-19 Patients in PII Off-the-Shelf Cell Therapy Program for ARDS
April 14, 2020
- Health Minister Vows to Shorten Review Time for Avigan
April 14, 2020
- Shimadzu to Roll Out Coronavirus Detection Regent Kit on April 20
April 14, 2020
Japan’s pharmaceutical industry is undergoing a structural shift in its workforce, with the role of sales reps shrinking while production…
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…